HeraMED Ltd. (AU:HMD) has released an update.
HeraMED Ltd has seen impressive user adoption of its HeraCARE platform, with over 3,800 expectant mothers registered and more than 710 active users, highlighting significant growth primarily due to the platform’s successful implementation at Broward Health in Florida. The platform has improved maternity care by enabling timely interventions and has recently been enhanced with nine clinically validated care plans and a Spanish language version. These developments, along with a favorable reimbursement landscape in Florida, suggest a promising expansion and revenue potential for HeraMED’s digital maternity care solution.
For further insights into AU:HMD stock, check out TipRanks’ Stock Analysis page.
